ResearcherUniversity of PittsburghActive in the last 2 years
Song Li
Matched on ORCID iD 0000-0003-1658-949X; OpenAlex author ID A5100448223; NIH RePORTER profile ID 8233471. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 2
- Labs led
- 1
- Collaborators
- 2
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 grants
Papers 2
- Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier. Co-author DOI 10.1016/j.mattod.2022.11.008↗
- Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. Last author DOI 10.1016/j.actbio.2020.01.039↗
Grants 2
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jingjing Sun · 2 shared papers, 2020–2023 · strength 0.26
- Paper Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-ba… DOI 10.1016/j.mattod.2022.11.008↗
- Paper Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. DOI 10.1016/j.actbio.2020.01.039↗
- Zhuoya Wan · 2 shared papers, 2020–2023 · strength 0.26
- Paper Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-ba… DOI 10.1016/j.mattod.2022.11.008↗
- Paper Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. DOI 10.1016/j.actbio.2020.01.039↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.